| | | | |
CUSIP No. 03748R754 | | | | Page 11 of 17 Pages |
Item 3. Source or Amount of Funds or Other Consideration.
Item 3 to the Schedule 13D is hereby amended and restated as follows:
The source and amount of funds used by each of WI and WCCL to purchase its Stock is Working Capital. As used herein, the term “Working Capital” includes income from the business operations of each entity plus sums borrowed from, among other sources, banks and brokerage firm margin accounts, to operate such business in general.
Item 4. Purpose of Transaction.
Item 4 to the Schedule 13D is hereby amended and restated as follows:
Pursuant to a series of transactions ending on October 7, 2022, WI has purchased an aggregate of 7,857,295 shares of Stock for an aggregate of $49,898,325 in cash. The shares of Stock were acquired by WI for the purpose of investment.
Pursuant to a series of transactions ending on June 22, 2022, WCCL has purchased an aggregate of 1,177,111 shares of Stock for an aggregate of $7,007,883 in cash. The shares of Stock were acquired by WCCL for the purpose of investment. Pursuant to a series of transactions ending on November 3, 2022, WCCL has sold for an aggregate of $2,038,792 in cash an aggregate of 226,661 shares of Stock.
Subject to the foregoing, the Reporting Persons intend to continue to evaluate the Issuer’s business, prospects and financial condition, the market for the Stock, monetary and stock market conditions and other further developments. As a part of such evaluation, one or more of the Reporting Persons may participate in meetings or hold discussions with the Issuer’s management, other shareholders and other persons in which the Reporting Persons may express their views with respect to potential changes in the operations, assets, capital structure or ownership of the Issuer as a means of enhancing shareholder value. Such expression of views may relate to one or more of the transactions specified in clauses (a) through (j) of Item 4 of this Schedule 13D.
Depending upon, among other things, the factors set forth above, the Reporting Persons reserve the right to (i) dispose of all or part of their investment in the Stock at any time, (ii) acquire additional shares of Stock by tender offer, in the open market, in private transactions or otherwise, (iii) propose a merger or similar business combination with the Issuer or its affiliates, (iv) seek control of the Issuer by stock ownership or otherwise, or (v) take any other action with respect to the Issuer.
Except as set forth in this Item 4, the Reporting Persons have no present plans or proposals that relate to or that would result in any of the following actions:
(a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;
(b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;
(c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries;
(d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board;